CVCT - Jason Dixson Photography - 114537

Boehringer Ingelheim Fellowship Program

CVCT+-+Jason+Dixson+Photography+-+113428

How can I (or my colleague) apply?

Please contact the chairs of CVCT

  • Pr Faiez Zannad

  • Dr Bertram Pitt

What Can the Fellowship Offer?

  • Work with Executive/Steering Committees and clinician scientists in Boehringer Ingelheim on CV outcome trial(s).

  • Undertake analyses of datasets that complements the fellow’s interest.

APPLICATION DEADLINE: January 31, 2021

ADVANCED FELLOWSHIP IN CV TRIALS

What problem are we trying to solve?

  • Without a steady supply of talent, innovation in outcome-based cardiovascular drug/device development is at risk.

  • Currently, there are only limited opportunities, if any, for clinical academics to gain expertise in the conduct of these global trials.

Why Boehringer Ingelheim?

  • Boehringer Ingelheim has a strong legacy of cardiovascular outcome trials, including EMPA-REG OUTCOME and Emperor-Reduced trials.

  • As a family-owned company, Boehringer Ingelheim plans in generations.

  • This partnership with CVCT is a unique opportunity to nurture future leaders in cardiovascular medicine.

Global Cardio    ascular

Clinical Trialists Forum

THE GLOBAL CVCT FORUM IS BRINGING ITS UNIQUENESS TO YOU!

Stay informed

Subscribe to our newsletter

© 2020 by STORYBOROS for CVCT Forum. All rights reserved.